NCT00779389 Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family Status COMPLETED Phase PHASE1
NCT00774319 TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT00771641 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE3
NCT00765440 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Status COMPLETED Phase PHASE3
NCT00765011 TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer Status COMPLETED Phase PHASE2
NCT00757549 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx Status COMPLETED Phase EARLY_PHASE1
NCT00756951 Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00756795 Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study) Status WITHDRAWN Phase NA
NCT00751816 Head & Neck Cancer Survivorship: Physical and Functional Status Status COMPLETED Phase N/A
NCT00750555 Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00738868 Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00738751 Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers Status COMPLETED Phase PHASE1
NCT00735826 A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer Status COMPLETED Phase NA
NCT00731380 A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00721513 Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00720304 Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00720083 Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00720070 PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer Status UNKNOWN Phase PHASE3